ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2163

Depressive Symptoms in Patients Consulting for the First Time at the Division of Rheumatology

Cristian Troitiño1, Anastasia Secco2, Marta Mamani3, Priscila Marcaida3, Santiago Scarafia4, Vanesa Duarte5, Virginia Durigan6, Geraldyn Calizaya7, Jorgelina Lares1 and Veronica Sandoval8, 1Reumatologia, Hospital Bernardino Rivadavia, CAPITAL FEDERAL, Argentina, 2Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 3Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina, 4Hospital Bernardino Rivadavia, CABA, Argentina, 5Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 6Reumatology, Hospital Bernardino Rivadavia, Ciudad autonoma de buenos aires, Argentina, 7Reumatology, Hospital Bernardino Rivadavia, ciudad autonoma de buenos aires, Argentina, 8Hospital Bernardino Rivadavia, CAPITAL FEDERAL, Argentina

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Rheumatology and depression

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Epidemiology and Public Health - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Depression can easily go unnoticed in routine clinical care. The delay in the diagnosis may increase the risk of chronicity, the number of visits, health care costs and deteriorates the quality of life. . The aims of our study was to estimate the prevalence of depressive symptoms in patients consulting for the first time and determine if patients with depression had different reasons for consultation and highest score in the visual analog scale (VAS) of pain than patients without depression.

Methods: A observational, prospective study was performed. We included patients who consulted for the first time in Rheumatology Service, excluding these with psychiatric treatments and rheumatic diseases. The PHQ-9 (Patient Health Questionnaire) evaluated the presence of depressive symptoms in the last two weeks. According to the score, they were classified in 4 categories: (1) major depressive syndrome, (2) other depressive disorders, (3) positive depressive symptoms and (4) negative depressive symptoms. To perform the analysis the patients were divided into those with a depressive disorder (1 and 2) and those who did not have it (3 and 4). T-test or Mann Whitney test was used as sample size distribution for continuous variables. Chi square or Fisher exact test was used as expected frequency distribution table for categorical variables. Multivariate logistic regression analysis taking depression as the dependent variable was performed.

Results: 121 patients were included in the study. 86% were women, mean age of 49±15 years. The most frequent reasons for consultations were polyarthralgia (35.5%) and back pain (13%). According PHQ-9, 37% of patients were classified in major depressive syndrome and 19% in other depressive disorders. No statistically significant differences between patients with and without a depressive disorder in terms of different reasons were found. However, patients with depressive disorders were more VAS pain (7, IQR 5-8) than patients without depression (5, IQR 4-6) and more days with pain in the week (7, IQR 5-7 vs 5, IQR 3-7), both with p <0.01. Increased frequency of self-medication (61% vs 39%) and sleep disorders (63% vs 37%) among patients with depressive disorders was observed, although these differences were not statistically significant. In the multivariate analysis, the only variable that was found associated with depression was independently VAS pain (OR 1.33, CI 1.13-1.56).

Conclusion: High percentage of patients had a depressive disorder with higher frequency and pain perception. So rheumatologists should be aware of this problem in order to make a proper diagnosis, optimize the application of complementary studies, and perform a multidisciplinary approach to the patient.


Disclosure: C. Troitiño, None; A. Secco, None; M. Mamani, None; P. Marcaida, None; S. Scarafia, None; V. Duarte, None; V. Durigan, None; G. Calizaya, None; J. Lares, None; V. Sandoval, None.

To cite this abstract in AMA style:

Troitiño C, Secco A, Mamani M, Marcaida P, Scarafia S, Duarte V, Durigan V, Calizaya G, Lares J, Sandoval V. Depressive Symptoms in Patients Consulting for the First Time at the Division of Rheumatology [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/depressive-symptoms-in-patients-consulting-for-the-first-time-at-the-division-of-rheumatology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depressive-symptoms-in-patients-consulting-for-the-first-time-at-the-division-of-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology